Evidence map›Paper›PMID 32963314›Full record

ArticleScientific reports2020

Alternative splicing of MR1 regulates antigen presentation to MAIT cells.

Gitanjali A Narayanan, Abhinav Nellore, Jessica Tran, Aneta H Worley, Erin W Meermeier, Elham Karamooz, Megan E Huber, Regina Kurapova, Fikadu G Tafesse, Melanie J Harriff and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Sorting endosomes play key roles in presentation ofbioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Ligand-dependent downregulation of MR1 cell surface expression.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Gitanjali A NarayananDepartment of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA.
Abhinav NelloreDepartment of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA.
Jessica TranVA Portland Health System, Portland, OR, USA.
Aneta H WorleyVA Portland Health System, Portland, OR, USA.
Erin W MeermeierDepartment of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, OR, USA.
Elham KaramoozVA Portland Health System, Portland, OR, USA.
Megan E HuberVA Portland Health System, Portland, OR, USA.
Regina KurapovaVA Portland Health System, Portland, OR, USA.
Fikadu G TafesseDepartment of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA.
Melanie J HarriffVA Portland Health System, Portland, OR, USA.
David M LewinsohnVA Portland Health System, Portland, OR, USA. lewinsod@ohsu.edu.
Oregon Health & Science University · USVA Portland Health Care System · US

Funding

Multidisciplinary Research Training in Pulmonary MedicineT32HL083808 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M., SLATORE, CHRISTOPHER G. · 2008 to 2025
$5.3M
Recognition of Mtb-infected Cells by CD8+ T LymphocytesR01AI048090 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M. · 2001 to 2016
$4.2M
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. TuberculosisR01AI134790 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M., WALZL, GERHARD · 2018 to 2022
$3.3M
Distinct pathways for MR1 antigen presentation upon infection with intracellular versus extracellular pathogensR01AI129976 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI HARRIFF, MELANIE J · 2017 to 2021
$1.9M
MR1-dependent presentation of Mycobacterium tuberculosis: a unique role for calcium signalingK08AI153359 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI KARAMOOZ, ELHAM · 2020 to 2024
$925k
Defining the role of host lipid repertoire in Mycobacterium tuberculosis infectionR21AI124225 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI TAFESSE, FIKADU G. · 2017 to 2018
$424k
Impact of COPD on Lung-Resident MAIT Cell Frequency, Function and Recognition of Bacterial InfectionI01CX001562 · VA · PORTLAND VA MEDICAL CENTER · PI HARRIFF, MELANIE J · 2018 to 2021
–
BLRD VA I01 BX000533CSRD VA I01 CX001562NHLBI NIH HHS T32 HL083808NIAID NIH HHS K08 AI153359NIAID NIH HHS R01 AI048090NIAID NIH HHS R01 AI129976NIAID NIH HHS R01 AI134790NIAID NIH HHS R21 AI124225
6 · The paper itself

Abstract

Mucosal Associated Invariant T (MAIT) cells can sense intracellular infection by a broad array of pathogens. These cells are activated upon encountering microbial antigen(s) displayed by MR1 on the surface of an infected cell. Human MR1 undergoes alternative splicing. The full-length isoform, MR1A, can activate MAIT cells, while the function of the isoforms, MR1B and MR1C, are incompletely understood. In this report, we sought to characterize the expression and function of these splice variants. Using a transcriptomic analysis in conjunction with qPCR, we find that that MR1A and MR1B transcripts are widely expressed. However only MR1A can present mycobacterial antigen to MAIT cells. Coexpression of MR1B with MR1A decreases MAIT cell activation following bacterial infection. Additionally, expression of MR1B prior to MR1A lowers total MR1A abundance, suggesting competition between MR1A and MR1B for either ligands or chaperones required for folding and/or trafficking. Finally, we evaluated CD4/CD8 double positive thymocytes expressing surface MR1. Here, we find that relative expression of MR1A/MR1B transcript is associated with the prevalence of MR1 + CD4/CD8 cells in the thymus. Our results suggest alternative splicing of MR1 represents a means of regulating MAIT activation in response to microbial ligand(s).

Indexed as

A549 CellsAlternative SplicingAntigen PresentationCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell LineCell Line, TumorHEK293 CellsHistocompatibility Antigens Class IHumansLigandsLymphocyte ActivationMinor Histocompatibility AntigensMucosal-Associated Invariant T CellsProtein IsoformsProtein TransportHistocompatibility Antigens Class ILigandsMinor Histocompatibility AntigensMR1 protein, humanProtein Isoforms

Identifiers

PMID32963314
PMCPMC7508857
OpenAlexW3088063219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.